Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-42.95M
Near historical average
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-44.92M
Historical baseline
PeriodValueYoY Change
TTM$-42.95M+15.0%
2024$-50.52M+22.6%
2023$-65.28M-5.9%
2022$-61.66M-18.4%
2021$-52.08M-226.4%
2020$-15.96M+38.7%
2019$-26.01M-